Your browser doesn't support javascript.
loading
An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients.
Sonia, Shamsun Nahar; George, Sherie; Shahi, Srushti R; Ali, Zahra; Abaza, Abdelrahman; Jamil, Aneeque; Gutlapalli, Sai Dheeraj; Ali, Marya; Oble, Mrinal J P; Yu, Ann Kashmer.
Afiliação
  • Sonia SN; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • George S; General Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Shahi SR; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Ali Z; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Abaza A; Pathology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Jamil A; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Gutlapalli SD; Internal Medicine, Richmond University Medical Center, New York, USA.
  • Ali M; Internal Medicine Clinical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Oble MJP; Psychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Yu AK; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus ; 15(7): e42045, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37602095

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos